PodcastIntel
Sign in Get Started Free
CNA
CNA

Moderna, Merck say mRNA treatment cuts risk of melanoma recurrence, spread

Aug 20, 2026 · 0:04:42
✨ AI Summary
  • Moderna and Merck's mRNA vaccine cuts melanoma risk.
  • First positive final-stage trial for mRNA cancer therapy.
  • Poh Kok Ing explains the new skin cancer treatment.

More from CNA

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to CNA and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →